NATCO Pharma Limited (NSE:NATCOPHARM)

NATCO Pharma Revenue

NATCO Pharma had revenue of 6.47B INR in the quarter ending December 31, 2025, with 36.33% growth. This brings the company's revenue in the last twelve months to 45.63B, up 6.60% year-over-year. In the fiscal year ending March 31, 2025, NATCO Pharma had annual revenue of 44.32B with 10.74% growth.

• Revenue (ttm): 45.63B
• Revenue Growth: +6.60%
• P/S Ratio: 4.61
• Revenue / Employee: 10.87M
• Employees: 4,199
• Market Cap: 210.40B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	44.32B	4.30B	10.74%
Mar 31, 2024	40.02B	12.94B	47.76%
Mar 31, 2023	27.09B	7.62B	39.17%
Mar 31, 2022	19.46B	-1.10B	-5.35%
Mar 31, 2021	20.56B	1.41B	7.37%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error